Sernova Biotherapeutics Inc. (T.SVA)

Last Closing Price: --

Cash Flow from Financial Activities (Quarterly)

Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.

Sernova Biotherapeutics Inc. (T.SVA) had Cash Flow from Financial Activities of 2.89M for the most recently reported fiscal quarter, ending 2026-07-31.

Figures for fiscal quarter ending 2026-07-31
Income Statement Financials
--
-1.81M
--
--
--
-1.52M
--
-1.84M
-1.84M
-1.81M
-1.81M
-1.81M
-1.81M
-1.52M
-1.51M
377.64M
377.64M
-0.01
-0.01
Balance Sheet Financials
--
--
--
0.27M
--
--
--
8.68M
-17.02M
-8.41M
-8.41M
377.64M
Cash Flow Statement Financials
-3.04M
--
Cash Flow from Financial Activities
2.89M
0.19M
0.05M
-0.14M
1.02M
--
--
Fundamental Metrics & Ratios
0.03
--
--
-0.01
-0.22
--
--
--
--
--
--
-3.04M
--
--
--
--
--
--
--
10.64%
21.52%
-676.25%
21.66%
-0.03
-0.01
-0.01